|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/574 | |||
| A61K 31/00 |
| (11) | Number of the document | 2533047 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12182790.1 |
| Date of filing the European patent application | 2008-09-18 | |
| (97) | Date of publication of the European application | 2012-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0718167 | 2007-09-18 | GB |
| (72) |
Slettenaar, Violet, GB
Wilson, Julia, GB
Wang, Yaohe, GB
Schioppa, Tiziana, GB
Balkwill, Frances, GB
|
| (73) |
Cancer Research Technology Limited,
Angel Building 407 St John Street, London EC1V 4AD,
GB
|
| (54) | CCR4 AS THERAPEUTIC TARGET FOR CANCER |
| CCR4 AS THERAPEUTIC TARGET FOR CANCER |